Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Watts

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Biological Chemistry|February 8, 2011
Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAsJiaxin Hu, Keith T Gagnon, Jing Liu, et al.
Frontiers in Neuroscience|March 7, 2024
EZH2 inhibition reactivates epigenetically silenced <i>FMR1</i> and normalizes molecular and electrophysiological abnormalities in fragile X syndrome neuronsMinggang Fang, Sara K Deibler, Pranathi Meda Krishnamurthy, et al.
Nature Communications|February 17, 2024
Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scopeNathan Bamidele, Han Zhang, Xiaolong Dong, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
<i>CRYPTID-exon</i>: streamlined detection of cryptic exons from RNA-seq dataEraj S Khokhar, Kaitlyn Brokaw, Zachary J Kartje, et al.
Nature Communications|July 8, 2018
Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editingAamir Mir, Julia F Alterman, Matthew R Hassler, et al.
Nucleic Acid Therapeutics|January 18, 2018
Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded RepeatLiande Li, Xiulong Shen, Zhongtian Liu, et al.
Nucleic Acids Research|March 29, 2025
Next generation APOBEC3 inhibitors: optimally designed for potency and nuclease stabilityAdam K Hedger, Wazo Myint, Jeong Min Lee, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Next generation APOBEC3 inhibitors: Optimally designed for potency and nuclease stabilityAdam K Hedger, Wazo Myint, Jeong Min Lee, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNAHannah M Pendergraff, Pranathi Meda Krishnamurthy, Alexandre J Debacker, et al.
Oncogene|August 1, 1993
Expression and amplification of cyclin genes in human breast cancerM F Buckley, K J Sweeney, J A Hamilton, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Biological Chemistry|February 8, 2011
Allele-selective inhibition of ataxin-3 (ATX3) expression by antisense oligomers and duplex RNAsJiaxin Hu, Keith T Gagnon, Jing Liu, et al.
Frontiers in Neuroscience|March 7, 2024
EZH2 inhibition reactivates epigenetically silenced <i>FMR1</i> and normalizes molecular and electrophysiological abnormalities in fragile X syndrome neuronsMinggang Fang, Sara K Deibler, Pranathi Meda Krishnamurthy, et al.
Nature Communications|February 17, 2024
Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scopeNathan Bamidele, Han Zhang, Xiaolong Dong, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
<i>CRYPTID-exon</i>: streamlined detection of cryptic exons from RNA-seq dataEraj S Khokhar, Kaitlyn Brokaw, Zachary J Kartje, et al.
Nature Communications|July 8, 2018
Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editingAamir Mir, Julia F Alterman, Matthew R Hassler, et al.
Nucleic Acid Therapeutics|January 18, 2018
Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded RepeatLiande Li, Xiulong Shen, Zhongtian Liu, et al.
Nucleic Acids Research|March 29, 2025
Next generation APOBEC3 inhibitors: optimally designed for potency and nuclease stabilityAdam K Hedger, Wazo Myint, Jeong Min Lee, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Next generation APOBEC3 inhibitors: Optimally designed for potency and nuclease stabilityAdam K Hedger, Wazo Myint, Jeong Min Lee, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNAHannah M Pendergraff, Pranathi Meda Krishnamurthy, Alexandre J Debacker, et al.
Oncogene|August 1, 1993
Expression and amplification of cyclin genes in human breast cancerM F Buckley, K J Sweeney, J A Hamilton, et al.
Pageof 19